Wordt geladen...
Timing of dornase alfa inhalation for cystic fibrosis
BACKGROUND: Inhalation of the enzyme dornase alfa reduces sputum viscosity and improves clinical outcomes of people with cystic fibrosis. This is an update of a previously published Cochrane review. OBJECTIVES: To determine the effect of timing of dornase alfa inhalation on measures of clinical effi...
Bewaard in:
| Gepubliceerd in: | Cochrane Database Syst Rev |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6474180/ https://ncbi.nlm.nih.gov/pubmed/27457496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007923.pub4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|